Cangzhou Senary Chemical Science Tech Co Ltd | CAS 1243308-37-3 | End Use API | Intermediate

Also known as: 1243308-37-3, Ethanediamide impurity c hcl, Ethyl 2-[(5-chloropyridin-2-yl)amino]-2-oxoacetate;hydrochloride, Ethyl 2-((5-chloropyridin-2-yl)amino)-2-oxoacetate hcl, Schembl616304, Bcp09599

Molecular Formula

C₉H₁₀Cl₂N₂O₃

Molecular Weight

265.09 g/mol

InChI Key

AZWJPQKNPCTYCU-UHFFFAOYSA-N

1 2D Structure

CAS 1243308-37-3

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

ethyl 2-[(5-chloropyridin-2-yl)amino]-2-oxoacetate;hydrochloride

2.1.2 InChI

InChI=1S/C9H9ClN2O3.ClH/c1-2-15-9(14)8(13)12-7-4-3-6(10)5-11-7;/h3-5H,2H2,1H3,(H,11,12,13);1H

2.1.3 InChI Key

AZWJPQKNPCTYCU-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CCOC(=O)C(=O)NC1=NC=C(C=C1)Cl.Cl

2.2 Synonyms

2.2.1 Depositor-Supplied Synonyms

1. 1243308-37-3

2. Ethanediamide Impurity C Hcl

3. Ethyl 2-[(5-chloropyridin-2-yl)amino]-2-oxoacetate;hydrochloride

4. Ethyl 2-((5-chloropyridin-2-yl)amino)-2-oxoacetate Hcl

5. Schembl616304

6. Bcp09599

7. Cs-m3402

8. Mfcd28502492

9. 2-((5-chloropyridin-2-yl)amino)2-oxoacetic Acid Ethyl Ester Monohydrochloride

10. 2-[(5-chloropyridin-2-yl)amino]-2-oxoacetate Ethyl Ester Monohydrochloride

11. Akos025287133

12. Ds-9233

13. Ac-33548

14. Ethyl 2-(5-methylpyridin-2-ylamino)-2-oxoacetate

15. Ethyl2-((5-chloropyridin-2-yl)amino)-2-oxoacetatehydrochloride

16. 2-[(5-chloropyridin-2-yl)amino]-2-oxoacetic Acid Ethyl Ester Monohydrochloride

17. Acetic Acid, 2-[(5-chloro-2-pyridinyl)amino]-2-oxo-, Ethyl Ester, Hydrochloride (1:1)

18. Acetic Acid, 2-[(5-chloro-2-pyridinyl)amino]-2-oxo-,ethyl Ester, Hydrochloride (1:1)

2.3 Create Date

2012-11-30

3 Chemical and Physical Properties

Molecular Formula	C₉H₁₀Cl₂N₂O₃
Molecular Weight	265.09 g/mol
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	4
Rotatable Bond Count	4
Exact Mass	264.0068476 g/mol
Monoisotopic Mass	264.0068476 g/mol
Topological Polar Surface Area	68.3 Å²
Heavy Atom Count	16
Formal Charge	0
Complexity	248
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	2

List of Suppliers

Full Screen View

Reset Filter

Ask Us

Cangzhou Senary Chemical Science-te...

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

China

Virtual Booth

Digital Content

Edoxaban Tosylate

PDF Supplier PDF

URL Supplier Web Content

CAS Number

1243308-37-3

Intermediate Name

2-((5-chloropyridin-2-yl)amino)-2-o...

About the Company

Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...

Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.

ASK
US